Literature DB >> 26815651

Paradigm-HF: a Paradigm Shift in Heart Failure Treatment?

Luis Cláudio Lemos Correia1, Anis Rassi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26815651      PMCID： PMC4728601          DOI： 10.5935/abc.20160009

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN： 0066-782X            Impact factor:   2.000


× No keyword cloud information.
  5 in total

1.  Neprilysin inhibition--a novel therapy for heart failure.

Authors:  Mariell Jessup
Journal:  N Engl J Med       Date:  2014-08-30       Impact factor: 91.245

2.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

3.  Angiotensin-neprilysin inhibition versus enalapril in heart failure.

Authors:  John J V McMurray; Milton Packer; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael R Zile
Journal:  N Engl J Med       Date:  2014-08-30       Impact factor: 91.245

4.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

5.  Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

Authors:  Milton Packer; Robert M Califf; Marvin A Konstam; Henry Krum; John J McMurray; Jean-Lucien Rouleau; Karl Swedberg
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690
  5 in total
  2 in total

1.  Application and impact of run-in studies.

Authors:  Michael Fralick; Jerry Avorn; Jessica M Franklin; Abdurrahman Abdurrob; Aaron S Kesselheim
Journal:  J Gen Intern Med       Date:  2018-02-15       Impact factor: 5.128

Review 2.  Spotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to date.

Authors:  José Fernando Vilela-Martin
Journal:  Drug Des Devel Ther       Date:  2016-05-09       Impact factor: 4.162
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.